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1 These authors contributed equally to this work.Hepatic stimulator substance (HSS) protects liver cells from various toxins by alleviating lesions
caused in the mitochondria. This paper demonstrates the necessity of the conserved CXXC catalytic
motif (C62–C65) for the mitochondria-targeted anti-apoptotic activity of HSS. Mutating the con-
served CXXC motif eliminated the protective effects against H2O2-induced apoptosis and diminished
the protection of the mitochondria. However, the mutation of the other disulﬁde bond C91–C108
mainly preserved the protection of mitochondria by HSS, implying that the conserved CXXC motif
and sulfhydryl oxidase (SOX) activity are essential for mitochondrial protection.
Structured summary:
MINT-7992635: HSS (uniprotkb:P55789) and HSS (uniprotkb:P55789) bind (MI:0407) by chromatography
technology (MI:0091)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Since its initial identiﬁcation in the cytosol of a newborn rat li-
ver by LaBrecque and Pesch [1] in 1975, hepatic stimulator sub-
stance (HSS) has been the subject of intense investigation. HSS
can stimulate the proliferation of hepatocytes and hepatoma cells
in vitro, promote liver regeneration after partial hepatectomy
[2,3], enhance the recovery of damaged hepatocytes and rescue
acute hepatic failure in vivo [4]. HSS has been shown to protect
the liver from acute injury caused by several compounds, including
CCl4, D-galactosamine, ethanol, H2O2 and cadmium.
Based on its growth-augmenting activity, HSS has also been
named as augmenter of liver regeneration (ALR). In 2001, Lisowsky
et al. ﬁrst reported that mammalian ALR is a FAD-linked sulfhydryl
oxidase (SOX) with a CXXC active motif at residues 62–65 in the
carboxy-terminal domain [5] that is capable of catalyzing disulﬁde
bond formation in a number of proteins [6]. According to the crys-
tallisation data [7], the recombinant HSS protein is a 30 kDa
homodimer in vitro and in vivo. Six cysteines form three disulﬁde
bonds within a subunit. Two cysteines (C15 and C124) are involved
in the head-to-toe intermolecular disulﬁde bonds that are corre-chemical Societies. Published by E
Cell Biology, Capital Medical
100069, China. Fax: +86 10lated with dimer formation. A CXXC motif is present between
C62 and C65, in agreement with a SOX redox-active disulﬁde.
C91 and C108 form the third structural disulﬁde bond. It is reason-
able to hypothesize that the enzymatic function of HSS might play
other roles in the cell. Alteration of SOX activity may affect the
other functions of HSS. He et al. reported that the site-directed
mutagenesis of either cysteine in the CXXC active site into serine
(Cys/Ser) not only inactivated the enzyme, but also inhibited c-
Jun phosphorylation and failed to potentate JAB1-mediated AP-1
activation [8].
Many recent publications have revealed that HSS has a potential
protective role in mitochondria. Like the homologous ERV1 pro-
tein, HSS was located in the mitochondrial intermembrane space.
HSS was shown to induce an increase in mitochondrial gene
expression and the oxidative phosphorylation capacity of liver
mitochondria [9]. Furthermore, HSS and the redox-regulated
receptor Mia40/Tim40 are components of a disulﬁde relay system
that mediates the import of proteins into the intermembrane space
of the mitochondria [10,11]. More recently, Thirunavukkarasu et al.
[12] reported that ALR is crucial for the survival of hepatocytes
through its association with mitochondria and regulation of ATP
synthesis. As alternative supporting data, our lab reported that
transfection of the hHSS gene into hepatoma cells desensitized
them to H2O2-induced cell apoptosis by preserving the mitochon-
dria [13] and inhibiting the mitochondrial permeability transition
[14]. All these evidences indicate that HSS protects hepatocytes
through its effect on mitochondria.lsevier B.V. All rights reserved.
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remain unknown. This report examines the relationship between
HSS enzymatic activity and its protection of the mitochondria.
We found that the anti-apoptotic function of HSS is strongly asso-
ciated with SOX activity.2. Materials and methods
2.1. Preparation of recombinant protein
HSS cDNA (375 base pairs) was ampliﬁed by PCR. The cysteine-
to-serine mutations of HSS at positions 62/65 of the CXXC motif
(CXXCmHSS) and 91 (C91SmHSS) were constructed using the
QuikChange Site-Directed Mutagenesis Kit (Stratagene). The gener-
ated PCR fragments were inserted into the His-tag pET-15b vector
(Novagen). Recombinant proteins were generated in the Origami
(DE3) Escherichia coli strain (Novagen) and puriﬁed using a His
GraviTrap Kit (Pharmacia) according to the manufacturer’s proto-
col. The puriﬁed proteins were desalted, concentrated and stored
at 80 C until further use. Protein concentration was estimated
using the BCA assay kit.
2.2. Enzyme assay of HSS and mHSS
Preparation of reduced lysozyme as a substrate for the HSS pro-
teins was performed as described elsewhere [15]. Enzyme assays
were performed according to the protocol described by Jeung-
Eun Lee et al. [16]. Brieﬂy, reduced lysozyme was incubated with
the added protein or equal amounts of pure FAD. Oxidation ofFig. 1. Expression, puriﬁcation and functional detection of wt HSS and the C62S/C65S pr
SDS–PAGE. Purity and dimerization of wt HSS and the C62S/C65S protein were evaluated
used as a negative control.the thiol groups was measured spectroscopically at 412 nm after
addition of 10 lM DTNB [5,50-dithiobis(2-nitrobenzoic acid)] by
determining the decrease in the absorbance at the listed time
points.
2.3. Cell culture, plasmid transfection and H2O2 treatment
The mammalian expression vector was constructed by inserting
the open reading frames of wild-type HSS, CXXCmHSS and
C91SmHSS into the pCMV-Flag vector. BEL-7402 hepatoma cells
were cultivated in DMEM containing 10% FCS at 37 C under 5%
CO2. To establish HSS-stable transfectants, BEL-7402 cells were
transfected with plasmids using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. Positive clones over-
expressing HSS were selected with 0.8 mg/ml G418 for 2 weeks.
The transfected cell lines were used for further study. For transient
expression, plasmids (vector, HSS or C91SmHSS) were transfected
48 h before treatment with H2O2.
For H2O2 treatment, cells were cultured and seeded one day be-
fore treatment. Based on the dose and time dependence of H2O2
toxicity, the administration of 0.6 mM H2O2 for 2–6 h was used
to induce apoptosis in the following experiments.
2.4. Apoptosis assay
For morphological assessment of cell apoptosis, the cells were
plated in 24-well plates and treated with 0.6 mM H2O2 for 6 h be-
fore ﬁxing and staining. Haematoxylin-eosin (HE) and Hoechst
33342 staining were used to morphologically evaluate cell apopto-
sis. For comparison, 500–1000 nuclei were observed for eachotein. Panel A shows the expression and puriﬁcation of recombinant HSS protein by
in panel B. Panel C indicates the SOX activity of wt HSS and C62S/C65S. Pure FAD was
Fig. 2. Transfection and Western-blot analysis of HSS expression. HSS and
CXXCmHSS (C62S/C65S) plasmids were stably transfected into BEL-7402 hepatoma
cells. In Panel A, the mitochondrial and cytosolic fractions were isolated and used to
detect the expression and localization of the protein using the anti-ﬂag antibody. In
Panel B, HSS dimerization was investigated. Aliquots of 25 lg of total protein
extract were separated with (+) or without () 10 mM DTT in the sample buffer.
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was also analysed using the Annexin V-FITC/PI Apoptosis Kit
(Biosea) by ﬂow cytometric analysis (Becton Dickinson FACScan).Fig. 3. Assessment of apoptosis by morphological detection and ﬂow cytometry. Cells we
Hoechst 33342 staining as shown in Panel A. Arrows indicate the condensation and mar
ratios from three independent experiments. Panel C shows the ﬂow cytometric analysis
experiments is shown in Panel D.To further assess the mitochondrial-dependent molecules involved
in apoptosis, caspase-3 activation was monitored using Quantikine
Active Caspase-3 Immunoassay kits (R&D Systems).
2.5. Mitochondrial damage
Cells were treated with 0.6 mM H2O2 for 2 h, and then the mito-
chondrial membrane potential (wm) was measured using JC-1
(10 lg/ml, Sigma-Aldrich) incorporation by the previously de-
scribed ﬂow cytometry method [17]. Cellular ATP content was ana-
lysed using the CellTiter-Glo Luminescent Cell Viability Assay Kit
(Promega) according to its instructions.
2.6. Isolation of cytosolic and mitochondrial fractions
Isolation of cytosol and mitochondria was performed according
to the instructions for the Mitochondria/Cytosol Isolation Kit
(Applygen Technologies). The mitochondrial pellet was resus-
pended, and the protein concentration was determined using the
BCA method.
2.7. Western blot
Western blot was performed as previously described [18] using
antibodies against FLAG (Sigma-Aldrich), cytochrome c (Cyt c),
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Santa Cruz
Biotechnology) and Cyt c oxidase subunit IV (COX IV), Bcl-2 (Cell
Signalling).
2.8. Statistical analysis
All data represent the average of at least three independent
experiments. Data are expressed as means ± S.D. Differencesre treated with 0.6 mM H2O2 for 6 h, and then apoptosis was evaluated using HE and
ginalisation of chromatin. Panel B shows the statistical evaluation of the apoptotic
of apoptosis. Statistical evaluation of the apoptotic ratios from three independent
3932 W. Li et al. / FEBS Letters 584 (2010) 3929–3935between groups were analysed using one-way ANOVA. P values of
less than 0.05 were considered signiﬁcant.3. Results and discussion
3.1. Sulfhydryl oxidase activity of recombinant HSS wt and C62S/C65S
proteins
To examine whether the enzymatic activity of HSS is related to
the conserved CXXC motif, cysteine was replaced with serine to
form C62S/C65S. The N terminus hexahistidine-tagged recombi-
nant proteins were expressed and puriﬁed in E. coli. As shown inFig. 4. Detection of mitochondrial damage in H2O2-induced apoptosis. (Panel A) Altera
(Panel B) Statistical evaluation of the mitochondrial transmembrane potential by ﬂow cy
analysis of mitochondrial Cyt c. Mitochondria were isolated and 10 lg of each sample
Caspase-3 activity was determined by ELISA.Fig. 1A and B, the recombinant wild-type HSS and C62S/C65S pro-
teins were puriﬁed and had a molecular weight of 15 kDa, which
corresponded to the monomeric form. In the absence of a reducing
agent, a homodimer of the HSS molecule was produced (Fig. 1B,
lanes 4 and 5). Wild-type HSS was able to oxidize lysozyme in a
time-dependent manner, while this ability was completely lost in
C62S/C65S due to the destruction of the redox-active disulﬁde
(Fig. 1C).
3.2. Expression and dimerization of HSS and mHSS in cells
HSS and CXXCmHSS plasmid were stably transfected into
BEL-7402 hepatoma cells. HSS expression was detected with thetion of the mitochondrial transmembrane potential as evaluated by JC-1 staining.
tometry assay. (Panel C) Alteration of cellular ATP content. (Panel D) Western-blot
were loaded. (Panel E) Western-blot analysis of the expression of Bcl-2. (Panel F)
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shown in Fig. 2A, HSS and mHSS could be detected in both the
mitochondria and cytosol of transfected cells. Fig. 2B showed that
in the samples of HSS-transfected cells (HSS-Tr) without DTT, in
addition to the 15 kDa band, a 30 kDa protein was detected that
corresponded to a homodimer. When DTT was added to the sam-
ples, a single band of 15 kDa representing the monomer was ob-
served. The same results were observed in mHSS-transfected cells
(mHSS-Tr), demonstrating that the substitution of cysteine with
serine in the CXXC motif neither changes the localization of the
protein nor interferes with the dimerization of HSS.
3.3. Overexpression of mHSS decreased the anti-apoptotic effect of HSS
in H2O2-induced cell apoptosis
The anti-apoptotic effect of HSS was previously reported. The
overexpression of HSS in cells confers resistance to H2O2 [13]
and radiation [19], with mechanisms involving mitochondrial
protection. However, the mechanisms by which HSS acts in theFig. 5. The HSSmutation at position 91 (C91S) and its effect on apoptosis. The SOX activit
was used as a negative control. After 48 h of transfection, H2O2 was added to the cell cult
cytometry (Panel C) and Dwm was measured (Panel D).mitochondria remain unknown. Elucidation of the molecular
mechanisms of HSS action will be a valuable contribution to our
understanding of liver protection. To explore the role of the
conserved CXXC motif of HSS in mitochondrial protection, cell
apoptosis was ﬁrst assayed. As shown in Fig. 3A, H2O2 treatment
induced changes in the nuclear morphology typical of apoptosis,
including membrane shrinkage, blebbing, chromatin condensation,
and the formation of apoptotic bodies. In the vector-Tr cells, the
apoptotic ratio was 37.00 ± 5.29% (Fig. 3B); this rate was markedly
reduced to a ratio of 20.00 ± 4.39% in the HSS-Tr cells, implying a
protective effect of HSS from apoptosis. However, the apoptotic ra-
tio was increased to 31.25 ± 2.98% in the mHSS-Tr cells (P < 0.05 vs.
HSS-Tr cells). Fig. 3C and D shows the evaluation of apoptosis by
ﬂow cytometry. As expected, treatment with H2O2 resulted in a
higher apoptotic ratio in the vector-Tr cells compared to the HSS-
Tr cells (P < 0.05). The percentage of apoptotic cells in the mHSS-
Tr cells was again increased (P < 0.05 vs. HSS-Tr cells), indicating
that the protection provided by HSS against cell apoptosis was de-
creased if the redox-active CXXC motif was mutated.y of recombinant wild-type HSS and C91SmHSS were measured (Panel A). Pure FAD
ure. The ATP content was determined (Panel B), cell apoptosis was analysed by ﬂow
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mitochondria-dependent apoptosis
Next, mitochondrial dysfunction and mitochondria-dependent
apoptosis were evaluated. Alteration of the mitochondrial
membrane potential, Dwm, is known to be an early event in the
apoptosis signalling process. JC-1 is a mitochondrial-speciﬁc dye
used to evaluate the mitochondrial membrane potential. Cells with
high Dwm form J-aggregates and thus show red ﬂuorescence. On
the other hand, cells with low Dwm maintain JC-1 in the mono-
meric form and thus show green ﬂuorescence. As shown in
Fig. 4A and B, exposure of the cells to H2O2 resulted in the severe
loss of Dwm in the vector-Tr group. The loss of Dwm in the HSS-
Tr cells appears to be signiﬁcantly improved, demonstrating the
protective effect of HSS in the mitochondria against injury
(P < 0.05). However, the Dwm decreased again in mHSS-Tr cells
(P < 0.05 vs. HSS-Tr).
ATP content was also observed, which serves as an index of
mitochondrial energy production. Fig. 4C shows that although
the ATP content in HSS-Tr cells was much higher than that of vec-
tor-Tr cells, the ATP content inmHSS-Tr cells was greatly decreased
when compared to the HSS-Tr cells (P < 0.05), implying that muta-
tion of the CXXC motif diminished the protective role of HSS in the
mitochondria.
To evaluate more precisely the role of mHSS in the mitochon-
dria-dependent apoptotic pathway, Cyt c leakage and expression
of Bcl-2 were detected by western blot. As shown in Fig. 4D, upon
H2O2 treatment, the Cyt c content was signiﬁcantly preserved in
HSS-Tr group compared with the decrease in the vector-Tr group.
However, the preservation of Cyt c was not observed in the mHSS
group. Similarly, Bcl-2 expression was increased in HSS-Tr cells
compared with a decrease in the vector-Tr group, while in mHSS-
Tr cells, the up-regulation of Bcl-2 was apparently inhibited
(Fig. 4E). Finally, caspase-3 enzymatic activity was quantiﬁed by
an enzyme-linked immunosorbent assay (ELISA). In vector-Tr cells,
caspase-3 activity was signiﬁcantly increased after H2O2 treatment
(Fig. 4F), while enzymatic activity was largely reduced in HSS-Tr
cells. In contrast, caspase-3 activity increased markedly in mHSS-
Tr cells compared with HSS-Tr cells (P < 0.05).
3.5. Effect of the C91S-HSS mutation on apoptosis
Of the two intermolecular disulﬁde bonds in HSS, C62–C65 con-
stitutes the highly conserved CXXC motif and is essential for SOX
activity. It remains unknown whether another disulﬁde bond-
forming motif such as C91–C108 contributes to SOX activity and
is involved in anti-oxidation. To address these questions, the cys-
teine at position 91 was mutated to serine, and the anti-apoptotic
effect on cells bearing C91SmHSS was examined. As shown in
Fig. 5A, the SOX activity of the recombinant C91S protein was lar-
gely preserved as compared to wild-type HSS. Although the cys-
teine mutation at C91 might alter the optimal status of HSS-FAD
binding [7], the anti-apoptotic effect was still comparable to the ef-
fect of wild-type HSS. When overexpressed in hepatoma cells,
C91SmHSS showed a similar protective effect upon H2O2 treatment
as the wild-type HSS group (Fig. 5B–D), with a decrease in the
apoptosis ratio and increases in Dwm and ATP content as compared
with the vector-Tr group. This evidence strongly supports the
observation that C91SmHSS did not alter the protective effect of
HSS on the mitochondria, thus implying that the anti-apoptotic ef-
fect of HSS is very closely related to the conserved CXXC motif at
C62–C65.
In summary, our study identiﬁes new evidence that HSS pro-
tection of hepatocytes could be related to its SOX enzymatic activ-
ity. This is the ﬁrst report exploring the close link between the
anti-apoptotic function and the SOX activity of HSS. Furthermore,HSS requires a conserved motif (CXXC at C62–C65) to maintain its
SOX activity. Mutation of this motif destroyed the enzymatic
activity and severely impaired the HSS protection of mitochon-
dria. The SOX activity of HSS is not related to other cysteine res-
idues such as C91. Our ﬁndings in this study lead to a new
understanding of the mechanism of HSS protection and could
form the basis of a new strategy for the development of new ther-
apeutics for liver disease patients. However, more detailed inves-
tigations are needed to identify speciﬁc compounds interacting
with the CXXC motif of HSS molecules. These future studies
may shed some light on the molecular mechanism underlying
HSS-mediated liver protection.
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